Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Advancing Selection of Next-Generation Oral Small Molecule PTH1R Agonist for Clinical Development Initiating Phase 1 Trial for SEP-631, MRGPRX2 NAM Program, for Mast Cell Diseases Updated Cash Runway Expected to Support Operating Plans at Least into 2029 SOUTH SAN FRANCISCO, […]
Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update GlobeNewswire August 11, 2025 Net income of $1.6 million and $5.3 million for the three and six months ended June 30, 2025, respectively; reaffirms full-year revenue guidance of $118-128 million Ping Zhang, Executive Chairman, appointed interim CEO as Dr.
Plug Power Second Quarter 2025 Highlights GlobeNewswire August 11, 2025 • Execution on Project Quantum Leap helps accelerate business salesgrowth and financial performance• Q2 revenue up 21% year-over-year, driven by broad hydrogen demand LATHAM, N.Y., Aug. 11, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the
(NasdaqGM:AQST), FDA accepts NDA submission for Anaphylm(TM); PDUFA date set for January 31, 2026 Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDA Company accelerates Anaphylm global expansion strategy to Canada and the EU Company to host investor call on August 12, 2025, at 8:00am ET WARREN, N.J., Aug.
Gevo Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025 Positive Net Income Attributable to Gevo of $2.1 million in the Second Quarter Positive Adjusted EBITDA1 of $17 million in the
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended June 30, 2025 GlobeNewswire August 11, 2025 Results for the Quarter Ended June 30, 2025 and Other Recent Highlights: Net investment income per share for the quarter was $0.39, compared to $0.37 for the quarter ended March 31, 2025 Net asset value per share
Harrow Announces Second-Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Second-Quarter 2025 and Recent Selected Highlights: Total revenues of $63.7 million, a 30% increase over $48.9 million recorded in the prior-year period GAAP net income of $5.0 million Adjusted EBITDA of $17.0 million Cash and cash equivalents of $53.0 million as of June 30, 2025
USA Rare Earth Reports its Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 STILLWATER, Okla., Aug. 11, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR” or the “Company”) today announced its financial and operational results for the second quarter and six months ended June 30, 2025. Second Quarter Highlights Stillwater, Oklahoma
Rapid7 to Participate in Upcoming Investor Conferences GlobeNewswire August 11, 2025 BOSTON, Aug. 11, 2025 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will be attending the following conferences: The Canaccord Genuity 45th Annual Growth Conference in Boston, MA. The presentation is scheduled
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results GlobeNewswire August 11, 2025 Selected 90 mg once-daily palazestrant for Part 2 of the OPERA-01 Phase 3 monotherapy trial and for the OPERA-02 Phase 3 trial in combination with ribociclib OPERA-01 enrollment ongoing with top-line data expected in the second half of 2026; OPERA-02 on